ISLAMABAD, September 19 — Longevity science, the fast-growing field that asks why humans age and whether the biological processes behind aging can be slowed, delayed or partially reversed, has moved from laboratory curiosity to serious clinical investigation, according to a body of research reviewed this week. The modern era of the field is often traced to discoveries in the 1930s, when researchers found that severely restricting calories extended the lifespan of laboratory rodents. Since then the work has widened to take in genetics, molecular biology and clinical trials.
A major milestone came in 1993, when Cynthia Kenyon and colleagues at the University of California, San Francisco, showed that a single gene mutation in the roundworm Caenorhabditis elegans could double its lifespan. That finding demonstrated aging is not fixed but is regulated by specific genes and biochemical pathways.
Conserved pathways, and what they respond to
Subsequent work identified conserved pathways such as insulin/IGF-1 signaling, mTOR and sirtuins, which respond to nutrients and stress and influence lifespan in yeast, worms, flies and mice. In mammals, caloric restriction and intermittent fasting have been shown to extend lifespan in mice and improve metabolic health in humans. The drug rapamycin, an mTOR inhibitor, extends lifespan in mice even when given late in life, and is now being studied in humans.
Other compounds, including metformin, NAD+ precursors and senolytics, are in various stages of clinical testing. The US National Institute on Aging, part of the National Institutes of Health, funds much of this research.
The measurement problem
A key challenge is that human lifespan studies take decades to complete, so researchers rely on biomarkers and healthspan measures. That constraint shapes how quickly any finding can be confirmed in people. The field also faces scientific debate.
Some researchers argue that aging is a disease that can be treated, while others see it as a natural process. Ethical and societal questions about access and inequality are also part of the conversation.
Despite hype around supplements and unproven treatments, the consensus among scientists is that the most reliable ways to promote longevity remain regular physical activity, a balanced diet, adequate sleep, not smoking, and managing chronic conditions. For readers weighing the steady stream of products marketed on the back of this research, the distinction matters. The evidence base for the everyday measures is established; the evidence base for most compounds sold as longevity aids is not.
What to watch next is the clinical testing now under way, including the human studies of rapamycin and the trials of metformin, NAD+ precursors and senolytics. Those results, not marketing claims, will settle what the biology can actually deliver. Consult your doctor for medical advice.
